Delivery Order SPE2DB20D3104-SPE2DB25FW0K8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $37,979.91 to AmerisourceBergen Drug Corp for the supply of methylergonovine 0.2 mg tablets in unit dose packaging of 20 tablets. This competitive award, issued on May 6, 2025, with an ultimate completion date of May 7, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's...
- The Defense Logistics Agency awarded a delivery order valued at $11,946.96 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/ml on a firm fixed-price basis. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of September 24, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction under a...
- This delivery order, awarded September 11, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of methylergonovine 0.2 mg tablets in quantities of 28 units. The contract is valued at $7,605.24 with a firm fixed price structure and no set-aside designation, indicating competitive award status. Performance will be executed from the awardee's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025....
- The Defense Logistics Agency awarded a $3,539.90 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Methylergonovine 0.2 mg tablets in packages of 12. The contract, with an ultimate completion date of September 19, 2025, represents a non-competitive, non-set-aside procurement delivered from AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $13,917.06 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Methylergonovine 0.2 mg/mL vials. This firm fixed-price contract, with an ultimate completion date of September 25, 2025, was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/ml in ampule form, valued at $3,170.91 with a firm fixed price arrangement. The contract is unclassified as a set-aside and was awarded on August 3, 2025, with an ultimate completion date of August 4, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $2,393.28 to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL in vials. This is a firm fixed-price contract with an ultimate completion date of September 29, 2025, and represents a competitively awarded, non-set-aside procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical distribution operations....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Methylergonovine 0.2 mg tablets (28-count) with a firm fixed price ceiling value of $1,547.44. The contract was competitively awarded with no set-aside designation and is scheduled for ultimate completion on August 22, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Methylergonovine 0.2 mg/mL in ampule form, with a firm fixed price ceiling value of $2,015.40 and an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for methylergonovine 0.2 mg/mL in a one-milliliter volume on July 9, 2025, with a ceiling value of $4,786.56. This firm fixed-price delivery order, which completes on July 10, 2025, represents a non-competitive set-aside award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Methylergonovine is an ergot alkaloid medication commonly used in obstetric and...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FW0K8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,734.54 to AmerisourceBergen Drug Corp for methylergonovine 0.2 mg tablets (28-count supply) on September 24, 2025, with an ultimate completion date of September 25, 2025. This firm fixed price delivery order was competitively awarded without any set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company's contract portfolio demonstrates extensive capability in delivering a comprehensive range of pharmaceutical products, medical supplies, brand-name and generic medications, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for methylergonovine, an ergot alkaloid medication, reflects the company's role in supplying essential pharmaceutical products to support Defense Health Agency and other federal healthcare customers globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/24/25 |